Showing results (1331-1340 of 1,965) with videos related to
Sort By:
Pageof 197
Stem Cells Translational Medicine|January 31, 2023
Unrelated Donor Cord Blood Transplantation in Children: Lessons Learned Over 3 DecadesJoanne Kurtzberg, Jesse D Troy, Kristin M Page, et al.British Journal of Haematology|July 27, 2001
Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children -- a Eurocord analysisT Niehues, V Rocha, A H Filipovich, et al.Journal of the American College of Cardiology|April 1, 2022
Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care PathwaysSaurabh Rajpal, Rami Kahwash, Matthew S Tong, et al.AIDS Research and Human Retroviruses|March 1, 1995
A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDAG Pialoux, J L Excler, Y Rivière, et al.AIDS Research and Human Retroviruses|December 1, 1995
Safety and immunogenicity of a recombinant HIV type 1 glycoprotein 160 boosted by a V3 synthetic peptide in HIV-negative volunteersD Salmon-Céron, J L Excler, D Sicard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemiaO Ringdén, M Labopin, A Bacigalupo, et al.Anticancer Research|September 1, 1992
Improved immunohistochemical detection of p53 protein in paraffin--embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parametersZ P Pavelic, J L Gluckman, M Gapany, et al.Science (New York, N.Y.)|July 6, 1984
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytesD Klatzmann, F Barré-Sinoussi, M T Nugeyre, et al.Bone Marrow Transplantation|June 28, 2005
Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term respondersH Bittencourt, V Rocha, A Filion, et al.Archives of Otolaryngology--Head & Neck Surgery|October 17, 1998
Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trialL L Gleich, J L Gluckman, S Armstrong, et al.Pageof 197